Medscape1d
New Ideas on PsA Pathogenesis May Drive New Treatments
Emerging evidence supports the argument that psoriatic arthritis arises from two pathways and that affected immune cells may ...
Which Is Better? Heat Vs. Cold For Psoriatic Arthritis
Discover how both heat and cold can impact psoriatic arthritis symptoms and learn which is best for your relief.
rheumatologyadvisor16h
Ustekinumab Biosimilar Steqeyma Gets FDA Approval
The FDA has approved Steqeyma® (ustekinumab-stba), a biosimilar to Stelara®, for the treatment of various chronic ...
dermatologyadvisor15h
Deucravacitinib Shows Promise in Psoriatic Arthritis Trials
Topline data were announced from two phase 3 trials evaluating deucravacitinib in adults with active psoriatic arthritis.
MoonLake initiates three new clinical trials and further expands the portfolio of indications for the Nanobody® sonelokimab
New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent ...
How Humidity Can Impact Psoriasis Symptoms
If you suffer from psoriasis, cooler weather could be bad news. Learn how high and low humidity levels can affect psoriasis ...
Cautious Hold Rating for ACELYRIN, INC. Amid Uncertainties in Lonigutamab’s Efficacy and Dosing
ACELYRIN, INC. (SLRN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Vikram ...
Simulations Plus reports Q1 adjusted EPS 17c, consensus 17c
Reports Q1 revenue $18.9M, consensus $18.8M. “We are off to a strong start to fiscal 2025 with total revenue increasing by 31% in the first ...